Biotechnology Stocks II: Dollar-cost Averaging for UroGen Pharma Ltd. (URGN)
Dollar-cost averaging calculator assumes a $1,000 initial investment and a recurring $100 monthly investment.
All values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| Dollar-cost Average Calculator Monthly Investments 2017/06/30 - 2025/05/21 | |
|---|---|
| Stock | URGN |
| Initial Price | $18.0600 |
| Initial Investment | $1,000.00 |
| Recurring Monthly Investment | $100.00 |
| Initial # Shares Bought | 55.3710 |
| DCA # Monthly Investments | 95 |
| DCA Total Monthly Investments | $9,500.00 |
| DCA # Monthly Shares Bought | 613.531 |
| DCA Total Investments | $10,500.00 |
| DCA Total # Shares | 668.902 |
| Final Price | $4.1700 |
| DCA Final Value of Total # Shares | $2,789.32 |
| DCA Percent Return | -73.44% |
| No DCA Total # Shares Bought | 55.3710 |
| No DCA Final Value | $230.90 |
| DCA Final Value - No DCA Final Value ($) | $2,558.42 |
| DCA Final Value - No DCA Final Value (%) | 1,108.04% |
| Stock Return Calculator | |
URGN Performance Table and Chart
URGN Compare Returns with S&P 500
URGN Trendline Chart
URGN Moving Average Chart
URGN Stock Return Map - See Patterns of Gains and Losses
URGN Stock Returns/Purchase Dates